Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-04-04 Sale | 2023-04-06 4:37 pm | Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD Director | 39,228 | $1.85 | $72,572 | 188,779 (Direct) | View |
| 2023-03-13 Purchase | 2023-03-14 8:39 pm | Jounce Therapeutics Inc. | JNCE | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner | 85,987 | $0.99966 | $85,958 | 5,300,087 (Indirect) | View |
| 2023-01-09 Sale | 2023-01-11 8:33 pm | Jounce Therapeutics Inc. | JNCE | Trehu Elizabeth Chief Medical Officer | 9,285 | $1.111 | $10,316 | 103,417 (Direct) | View |
| 2023-01-09 Sale | 2023-01-11 8:32 pm | Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President | 45,070 | $1.111 | $50,075 | 228,007 (Direct) | View |
| 2023-01-09 Sale | 2023-01-11 8:30 pm | Jounce Therapeutics Inc. | JNCE | Drapkin Kimberlee C CFO and Treasurer | 14,096 | $1.111 | $15,661 | 66,018 (Direct) | View |
| 2023-01-09 Sale | 2023-01-11 8:29 pm | Jounce Therapeutics Inc. | JNCE | Cole Hugh M Chief Operating Officer | 16,634 | $1.111 | $18,481 | 110,082 (Direct) | View |
| 2022-01-07 Sale | 2022-01-11 8:57 pm | Jounce Therapeutics Inc. | JNCE | Trehu Elizabeth Chief Medical Officer | 8,383 | $6.883 | $57,700 | 85,202 (Direct) | View |
| 2022-01-07 Sale | 2022-01-11 8:57 pm | Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President | 37,294 | $6.883 | $256,696 | 185,577 (Direct) | View |
| 2022-01-07 Sale | 2022-01-11 8:56 pm | Jounce Therapeutics Inc. | JNCE | Drapkin Kimberlee C CFO and Treasurer | 12,817 | $6.883 | $88,220 | 52,614 (Direct) | View |
| 2022-01-07 Sale | 2022-01-11 8:55 pm | Jounce Therapeutics Inc. | JNCE | Cole Hugh M Chief Business Officer | 9,673 | $6.883 | $66,580 | 64,216 (Direct) | View |
| 2021-11-12 Sale | 2021-11-16 7:57 pm | Jounce Therapeutics Inc. | JNCE | Third Rock Ventures III L.P. Third Rock Ventures GP III L.P. TRV GP III LLC STARR KEVIN P TEPPER ROBERT I LEVIN MARK J 10% Owner | 1,900,000 | $8.38 | $15,922,000 | 4,698,661 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-05-03 Other | 2023-05-05 4:38 pm | N/A N/A | Jounce Therapeutics Inc. | JNCE | Concentra Biosciences LLC 10% Owner | 10,000 | $0.97377 | 20,000 (Direct) | View |
| 2023-05-03 Equity Swap | 2023-05-05 4:37 pm | N/A N/A | Jounce Therapeutics Inc. | JNCE | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP Director 10% Owner | 5,300,087 | $1.85 | 20,000 (Indirect) | View |
| 2023-05-03 Other | 2023-05-05 4:37 pm | N/A N/A | Jounce Therapeutics Inc. | JNCE | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP Director 10% Owner | 10,000 | $9,738 | 20,000 (Indirect) | View |
Ownership | 2023-05-05 4:35 pm | N/A N/A | Jounce Therapeutics Inc. | JNCE | Concentra Biosciences LLC Concentra Merger Sub Inc. 10% Owner | 0 | $0 | 36,367,727 (Indirect) | View |
| 2023-05-03 Equity Swap | 2023-05-04 07:44 am | N/A N/A | Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD Director | 188,778 | $0 | 1 (Direct) | View |
| 2023-05-03 Equity Swap | 2023-05-04 07:44 am | N/A N/A | Jounce Therapeutics Inc. | JNCE | KARSEN PERRY A Director | 5,000 | $0 | 0 (Direct) | View |
| 2023-05-03 Equity Swap | 2023-05-04 07:44 am | N/A N/A | Jounce Therapeutics Inc. | JNCE | Kamen Robert Director | 94,850 | $0 | 0 (Direct) | View |
| 2023-05-03 Equity Swap | 2023-05-04 07:43 am | N/A N/A | Jounce Therapeutics Inc. | JNCE | Drapkin Kimberlee C President, CFO and Treasurer | 66,018 | $0 | 0 (Direct) | View |
Ownership | 2023-03-14 8:38 pm | N/A N/A | Jounce Therapeutics Inc. | JNCE | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner | 0 | $0 | 5,214,100 (Indirect) | View |
| 2022-08-01 Option Award | 2022-08-03 8:29 pm | N/A 2032-08-01 | Jounce Therapeutics Inc. | JNCE | Cole Hugh M Chief Operating Officer | 60,000 | $0 | 166,716 (Direct) | View |
| 2022-06-24 Option Award | 2022-06-28 9:08 pm | N/A 2032-06-24 | Jounce Therapeutics Inc. | JNCE | Salter-Cid Luisa Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-24 Option Award | 2022-06-28 9:08 pm | N/A 2032-06-24 | Jounce Therapeutics Inc. | JNCE | Raythatha Jigar Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-24 Option Award | 2022-06-28 9:07 pm | N/A 2032-06-24 | Jounce Therapeutics Inc. | JNCE | KARSEN PERRY A Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-24 Option Award | 2022-06-28 9:06 pm | N/A 2032-06-24 | Jounce Therapeutics Inc. | JNCE | Kamen Robert Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-24 Option Award | 2022-06-28 9:05 pm | N/A 2032-06-24 | Jounce Therapeutics Inc. | JNCE | Iannone Robert Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-24 Option Award | 2022-06-28 9:03 pm | N/A 2032-06-24 | Jounce Therapeutics Inc. | JNCE | Higgons John Duncan Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-24 Option Award | 2022-06-28 9:02 pm | N/A 2032-06-24 | Jounce Therapeutics Inc. | JNCE | Duncan Barbara Gayle Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-24 Option Award | 2022-06-28 9:00 pm | N/A 2032-06-24 | Jounce Therapeutics Inc. | JNCE | Diaz Luis Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-02-01 Option Award(A) | 2022-03-17 8:50 pm | N/A 2032-02-01 | Jounce Therapeutics Inc. | JNCE | Cole Hugh M Chief Business Officer | 85,000 | $0 | 85,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 7:38 pm | N/A 2032-02-01 | Jounce Therapeutics Inc. | JNCE | Cole Hugh M Chief Business Officer | 127,500 | $0 | 191,716 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 7:38 pm | N/A 2032-02-01 | Jounce Therapeutics Inc. | JNCE | Drapkin Kimberlee C CFO and Treasurer | 82,500 | $0 | 135,114 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 7:37 pm | N/A 2032-02-01 | Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President | 262,500 | $0 | 448,077 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 7:36 pm | N/A 2032-02-01 | Jounce Therapeutics Inc. | JNCE | Trehu Elizabeth Chief Medical Officer | 82,500 | $0 | 167,702 (Direct) | View |
| 2021-09-15 Other | 2021-09-17 4:15 pm | N/A N/A | Jounce Therapeutics Inc. | JNCE | Third Rock Ventures II L.P. Third Rock Ventures GP II L.P. TRV GP II LLC STARR KEVIN P TEPPER ROBERT I LEVIN MARK J 10% Owner | 1,750,000 | $0 | 8,348,661 (Direct) | View |